首页> 外文期刊>Diabetes >Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells.
【24h】

Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells.

机译:人类自身反应性GAD特异性T细胞中的差异性识别和激活阈值。

获取原文
获取原文并翻译 | 示例
       

摘要

The activation requirements of autoreactive CD4(+) T-cells were investigated in GAD65-specific HLA-DR0401-restricted clones derived from a diabetic patient using major histocompatibility complex (MHC) class II tetramers (TMrs) as stimulating agents. Despite the fact that TMrs loaded with an immunodominant-altered GAD peptide (TMr-GAD) bound a limited number of T-cell receptors, they were capable of efficiently delivering activation signals. These signals ranged from the early steps of phospholipase C (PLC)-gamma(1) phosphorylation and Ca(2+) mobilization to more complex events, such as CD69 upregulation, cytokine mRNA transcription and secretion, and proliferation. All the effects triggered by TMr-GAD were dose dependent. On the contrary, [(3)H]-thymidine incorporation decreased at high TMr-GAD concentrations because of activation-induced cell death (AICD) after initial proliferation. Lower-avidity clones (as defined by TMr-GAD binding) were less sensitive to activation as well as less susceptible to AICD compared with higher-avidity clones. Induction of apoptosis is a potential immunomodulatory target for therapeutic applications of MHC class II multimers, but the relative resistance of low-avidity T-cells may limit its benefits.
机译:使用主要组织相容性复合体(MHC)II类四聚体(TMrs)作为刺激剂,在糖尿病患者的GAD65特异性HLA-DR0401限制性克隆中研究了自身反应性CD4(+)T细胞的激活要求。尽管装载有免疫显性改变的GAD肽(TMr-GAD)的TMrs结合了有限数量的T细胞受体,但它们能够有效传递激活信号。这些信号的范围从磷脂酶C(PLC)-γ(1)磷酸化和Ca(2+)动员的早期阶段到更复杂的事件,例如CD69上调,细胞因子mRNA的转录和分泌以及增殖。 TMr-GAD触发的所有作用均与剂量有关。相反,在高TMr-GAD浓度下,[(3)H]-胸苷掺入减少,这是由于初始增殖后激活诱导的细胞死亡(AICD)。与较高亲和力的克隆相比,较低亲和力的克隆(由TMr-GAD结合定义)对激活的敏感性较低,对AICD的敏感性较低。凋亡的诱导是用于MHC II类多聚体治疗应用的潜在免疫调节靶标,但是低存活率T细胞的相对耐药性可能会限制其益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号